Clarity Pharmaceuticals reaches recruitment goal for prostate cancer trial
Clarity Pharmaceuticals (ASX:CU6) has exceeded recruitment targets for its registrational Phase 3 AMPLIFY trial in just nine months.
Clarity Pharmaceuticals (ASX:CU6) has exceeded recruitment targets for its registrational Phase 3 AMPLIFY trial in just nine months.
The Australian residential property market has reached an unprecedented milestone, with the total value of the nation's housing stock soaring to $12.3 trillion.
Lode Resources (ASX:LDR) commenced a high-priority, 32-hole drilling program at its flagship Uralla Gold Project.
Asian stocks rebounded from Monday's selloff and crude oil fell, as President Donald Trump signaled the Iran war may be ending soon. Bloomberg's Michael Heath has the latest.
Australian mining giant Fortescue (ASX:FMG) has finalised the acquisition of Alta Copper.
The Albanese government secured a key win as the Greens agree to pass the Division 296 super tax, targeting balances over $3 million.
Orica (ASX:ORI) projected FY26 first-half EBIT growth, driven by a 20% surge in Digital Solutions and strong mining chemical demand.
Telix Pharmaceuticals (ASX:TLX) has met the primary objectives for Part 1 of its ProstACT Global Phase 3 study.
Kincora Copper (ASX:KCC) announced an expansion and the commencement of advanced geophysical exploration at its wholly owned Cowal East Project.
Global biotechnology firm CSL (ASX:CSL) has broken ground on a $1.5 billion expansion of its manufacturing facility in Kankakee.
Australia has deployed RAAF Wedgetail aircraft and 85 personnel to the Middle East to bolster Gulf nation security and protect 115,000 Australians abroad.
Air New Zealand (ASX:AIZ) suspended its earnings guidance for the 2026 financial year, citing "unprecedented volatility" in global jet fuel markets.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade